versantis is a startup based in Switzerland.
Versantis is a pharmaceutical company and ETH Zürich spin-off developing transformative orphan drugs for liver and pediatric diseases, with a clinical-stage lead candidate VS-01 targeting acute liver diseases and associated organ failures.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.